[go: up one dir, main page]

BR9709930A - Compound pharmaceutical composition use of a compound and processes for treating a human or animal individual and for preparing a compound - Google Patents

Compound pharmaceutical composition use of a compound and processes for treating a human or animal individual and for preparing a compound

Info

Publication number
BR9709930A
BR9709930A BR9709930A BR9709930A BR9709930A BR 9709930 A BR9709930 A BR 9709930A BR 9709930 A BR9709930 A BR 9709930A BR 9709930 A BR9709930 A BR 9709930A BR 9709930 A BR9709930 A BR 9709930A
Authority
BR
Brazil
Prior art keywords
compound
treating
preparing
human
processes
Prior art date
Application number
BR9709930A
Other languages
Portuguese (pt)
Inventor
David George Allen
Colin David Eldred
Brian David Judkins
William Leonard Mitchell
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9613095.0A external-priority patent/GB9613095D0/en
Priority claimed from GBGB9613017.4A external-priority patent/GB9613017D0/en
Priority claimed from GBGB9613018.2A external-priority patent/GB9613018D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of BR9709930A publication Critical patent/BR9709930A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9709930A 1996-06-21 1997-06-19 Compound pharmaceutical composition use of a compound and processes for treating a human or animal individual and for preparing a compound BR9709930A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9613095.0A GB9613095D0 (en) 1996-06-21 1996-06-21 Therapeutic piperidines
GBGB9613017.4A GB9613017D0 (en) 1996-06-21 1996-06-21 Therapeutic compounds
GBGB9613018.2A GB9613018D0 (en) 1996-06-21 1996-06-21 Therapeutic indazoles
PCT/EP1997/003196 WO1997049699A1 (en) 1996-06-21 1997-06-19 Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders

Publications (1)

Publication Number Publication Date
BR9709930A true BR9709930A (en) 1999-08-10

Family

ID=27268341

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9709930A BR9709930A (en) 1996-06-21 1997-06-19 Compound pharmaceutical composition use of a compound and processes for treating a human or animal individual and for preparing a compound

Country Status (17)

Country Link
EP (1) EP0912555A1 (en)
JP (1) JP2000512648A (en)
KR (1) KR20000022041A (en)
AP (1) AP9801417A0 (en)
AR (1) AR008245A1 (en)
AU (1) AU3261197A (en)
BR (1) BR9709930A (en)
CA (1) CA2258753A1 (en)
CZ (1) CZ424698A3 (en)
EA (1) EA199801015A1 (en)
ID (1) ID17052A (en)
IL (1) IL127464A0 (en)
IS (1) IS4924A (en)
NO (1) NO985974L (en)
PL (1) PL330797A1 (en)
TR (1) TR199802665T2 (en)
WO (1) WO1997049699A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7642278B2 (en) 2001-07-03 2010-01-05 Novartis Vaccines And Diagnostics, Inc. Indazole benzimidazole compounds
EP1401831A1 (en) 2001-07-03 2004-03-31 Chiron Corporation Indazole benzimidazole compounds as tyrosine and serine/threonine kinase inhibitors
TW200401641A (en) * 2002-07-18 2004-02-01 Wyeth Corp 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands
KR20050101551A (en) 2003-02-14 2005-10-24 와이어쓰 Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
BRPI0709718A2 (en) 2006-04-05 2011-03-29 Wyeth Corp compound; method for treating a central nervous system disorder related to or affected by the 5-ht6 receptor in a patient in need; pharmaceutical composition; and process for the preparation of the compound
KR101132577B1 (en) 2007-01-10 2012-04-05 에프. 호프만-라 로슈 아게 Sulfonamide derivatives as chymase inhibitors
CN113655155A (en) * 2021-07-28 2021-11-16 任贤金 Method for measuring SPH3127 related substances

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4124942A1 (en) * 1991-07-27 1993-01-28 Thomae Gmbh Dr K 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENTS CONTAINING SUCH COMPOUNDS
JPH07501063A (en) * 1991-11-14 1995-02-02 グラクソ、グループ、リミテッド Piperidine acetic acid derivatives as fibrinogen-dependent platelet aggregation inhibitors
GB9208740D0 (en) * 1992-04-23 1992-06-10 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
WO1997049699A1 (en) 1997-12-31
ID17052A (en) 1997-12-04
JP2000512648A (en) 2000-09-26
AU3261197A (en) 1998-01-14
KR20000022041A (en) 2000-04-25
NO985974L (en) 1999-02-17
NO985974D0 (en) 1998-12-18
EA199801015A1 (en) 1999-08-26
AR008245A1 (en) 1999-12-29
PL330797A1 (en) 1999-06-07
EP0912555A1 (en) 1999-05-06
IL127464A0 (en) 1999-10-28
IS4924A (en) 1998-12-15
CA2258753A1 (en) 1997-12-31
TR199802665T2 (en) 1999-03-22
CZ424698A3 (en) 1999-05-12
AP9801417A0 (en) 1998-12-31

Similar Documents

Publication Publication Date Title
BR9610248A (en) Compound pharmaceutical composition processes for the treatment of pain and for the preparation of a compound and use of the compound
BR9710359A (en) Compound pharmaceutical formulation use of a compound and processes for the preparation of a compound and for treatment of a human or animal individual suffering from a disorder mediated by aberrant protein tyrosine kinase activity
BR9612204A (en) Compound use of the compound Pharmaceutical composition and process for preparing the compound and for treating pain
BR9702147A (en) Pharmaceutical composition use of a pharmaceutical composition and process for the treatment of pain associated with periodontal scarification and for the preparation of a pharmaceutical composition
BR9100435A (en) COMPOUND, PHARMACEUTICAL COMPOSITION, USE, METHOD OF TREATING AN ANIMAL, PROCESSES FOR THE PREPARATION OF A COMPOUND AND PHARMACEUTICAL COMPOSITION
BR9612309A (en) Compound use of a compound pharmaceutical composition aerosol combination pharmaceutical formulation and processes for the treatment of a human or animal individual with an anti-inflammatory and / or allergic condition and for the preparation of a compound
BR9602933A (en) Compound processes for preparation of compost and pharmaceutical composition and compost
BR9507656A (en) Compound use of a compound Pharmaceutical composition and processes for the treatment of a patient suffering from pain and for the preparation of a compound
BR9609467A (en) Compound use of a compound Pharmaceutical composition and processes for preparing a compound and treating plank aggregation disorders
BR9709915A (en) Compound pharmaceutical composition use of the compound and processes for the treatment or prevention of physiological disorders associated with an excess of tachykinins and for the preparation of the compound
BR9603919A (en) Antiparasitic composition for the treatment and protection of pets
BR9503812A (en) Compound pharmaceutical composition use method of treatment of a human process for the preparation of a compound
BR9604872A (en) Composition for hair treatment
BR9609532A (en) Antimicrobial composition for the treatment of hair process for the treatment of dandruff and use of the composition
DE69710095D1 (en) PHARMACEUTICAL PREPARATION FOR TREATING DIABETES
PT955995E (en) USING COMPLEXES FOR THE PREPARATION OF TREATMENT COMPOSITIONS FOR SENSITIVE SKINS, PREPARATION PROCESS AND HYPOALERGENIC COMPOUNDS
FI904092A7 (en) Pharmaceutical preparations for the treatment of severe pain conditions and method for their preparation
FI962908L (en) Antimicrobial composition, method of preparation thereof and use thereof
BR9711311A (en) Compound pharmaceutical composition use of a compound and processes for the preparation of compounds and for the treatment of a mammal including man
BR9505610A (en) Compound pharmaceutical composition process for the preparation of a compound use and method of treating inflammation and pain
BR9502471A (en) Guanidine compound Process for preparing a guanidine compound Pharmaceutical composition Use of a guanidine compound Method for the prophylactic or therapeutic treatment of diseases and process for preparing a pharmaceutical composition
BR9710376A (en) Antiviral compound use of the same pharmaceutical composition and process for prophylactic or therapeutic antiviral treatment of a human or non-human animal
BR9708607A (en) Compound pharmaceutical composition use of a compound process for treating or reducing the risk of inflammatory disease in a patient and for the preparation of a compound and chemical intermediate
EE9800234A (en) Method of treatment and pharmaceutical composition
BR9610733A (en) Compound processes for the preparation of it and for the treatment of a mammal pharmaceutical composition and use of a compound

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]